INFLUENZA VACCINATION VERSUS ANTI-VACCINATION MOVEMENTS: THE CASE OF BRAZIL
DOI:
https://doi.org/10.31052/1853.1180.v22.n2.20790Keywords:
Influenza, Human, Influenza Vaccines, Immunization Programs, Mass Vaccination, Anti-Vaccination MovementDownloads
References
1. BrazilianMinistryof Health. Portal Brasil - Campanha de vacinação contra a gripe começa na segunda-feira (17). [online] [accessed 2017-08-23]. Available from: http://www.brasil.gov.br/saude/2017/04/campanha-de-vacinacao-contra-gripe-comeca-na-segunda-feira-172. BrazilianMinistryof Health. Informe Técnico - 19ª Campanha Nacional de Vacinação contra a Influenza. [online]. Brasília; 2017 [accessed 2017-08-23]. Available from: http://pni.datasus.gov.br/sipni/03%2003%202017%20Informe_Cp_Influenza%20_%20final.pdf3. BrazilianMinistryof Health. Portal Brasil - Campanha de vacinação contra a gripe termina nesta sexta (26). [online] [accessed 2017-08-23]. Available from: http://www.brasil.gov.br/saude/2017/05/campanha-de-vacinacao-contra-a-gripe-termina-nesta-sexta-264. BrazilianMinistryof Health. Portal Brasil - Campanha de vacinação contra gripe vai até a sexta-feira (9). [online] [accessed 2017-08-23]. Available from: http://www.brasil.gov.br/saude/2017/06/campanha-de-vacinacao-contra-gripe-vai-ate-a-sexta-feira-95. BrazilianMinistryof Health. Portal Brasil - Vacinação contra a gripe atinge 92% do público-alvo. [online] [accessed 2017-08-23]. Available from: http://www.brasil.gov.br/saude/2016/05/vacinacao-contra-a-gripe-atinge-92-do-publico-alvo6. BrazilianMinistryof Health. Portal Brasil - Vacinação contra gripe será ampliada a toda a população a partir de segunda (5). [online] [accessed 2017-08-30]. Available from: http://www.brasil.gov.br/saude/2017/06/vacinacao-contra-gripe-sera-amplia-da-a-toda-a-populacao-a-partir-de-segunda-57. Sanches TT, Siqueira-Oliveira T, Papp-Moretti C, Tovani-Palone MR, Hishinuma G. Evolução do sistema público de saúde no Brasil frente ao estágio atual da prevenção do câncer de colo uterino em mulheres jovens e adolescentes. RevFacMed 2017;
73Revista de Salud Pública, (XXII) 2:69-73 Julio 2018Foro abierto de opinión, Marcos Roberto Tovani-Palone65(1): 115-20. 8. Takata R, Girardi A. Controvérsias em torno das va-cinas. ComCiência 2014; (162):0-0.9. Levi GC. Recusa de vacinas causas e consequências. São Paulo: Segmento Farma; 2013. Availablefrom: http://www.bravacinas.com.br/site/wp-content/uploads/2015/02/15487-Recusa-de-vacinas_5_set.pdf10. Vasconcellos-Silva PR, Castiel LD, Griep RH. The media-driven risk society, the anti-vaccination mo-vement and risk of autismo. Ciênc Saúde Coletiva 2015; 20(2): 607-16.11. Pereira BFB, Martins MAS, Barbosa TLA, Silva CSO, Gomes LMX. Motivos que levaram as ges-tantes a não se vacinarem contra H1N1. CiêncSaú-deColetiva 2013;18(6):1745-52. 12. Barbieri CL, Couto MT. Decision-making on chil-dhood vaccination by highly educated parents.Rev SaudePublica 2015;49:18. 13. Lansbury LE, Smith S, Beyer W, Karamehic E, Pasic-Juhas E, Sikira H, et al. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.Vaccine 2017;35(16):1996-2006.14. Sakala IG, Honda-Okubo Y, Fung J, Petrovsky N.Influenza immunization during pregnancy: bene-fits for mother and infant.Hum VaccinImmunother 2016;12(12):3065-3071.15. Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinen MM.Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis.Sleep Med Rev 2017. pii: S1087-0792(17)30001-1.16. Ghaderi S, Gunnes N, Bakken IJ, Magnus P, Trogs-tad L, Håberg SE.Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.Eur J Epidemiol 2016;31(1):67-72
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).
How to Cite
